 |
Articles: M&A/Partnerships |
Merck and Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease
Merck & Co., 07/10/09
Free full text
Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola
BayNews International, 07/09/09
Free full text
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
b3c newswire, 07/09/09 ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
b3c newswire, 07/09/09 euroPLX Introduces Dynamic Partnering Focus Concept, Announces euroPLX 41 Barcelona
b3c newswire, 07/09/09 Novation and Cancer Therapeutics establish collaboration for the discovery and development of new cancer therapies
b3c newswire, 07/09/09 Morphotek, Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Morphotek, 07/08/09
Free full text
Merge Gives Preliminary 2Q Numbers
HealthDataManagement, 07/08/09 Novation and Cancer Therapeutics establish collaboration for the discovery and development of new cancer therapies
b3c newswire, 07/07/09 Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
b3c newswire, 07/07/09 Cardinal Health renews distribution agreement with CVS Caremark
Cardinal Health, 07/07/09
Free full text
Novartis delivers 250,000,000th Coartem treatment and becomes first healthcare company to join United Against Malaria partnership
Novartis, 07/07/09
Free full text
ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
b3c newswire, 07/07/09 Johnson and Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Elan, 07/06/09
Free full text
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Cell Genesys, 07/01/09
Free full text
Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
Mylan, 06/30/09 Zila Enters into Merger Agreement with Tolmar
Zila, 06/26/09
Free full text
CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
CEL-SCI, 06/26/09 Trillium chooses Salumatics for records conversion
Canadian Healthcare Technology, 06/26/09
Free full text
Horizon inks distribution agreement with Sedecal
Canadian Healthcare Technology, 06/26/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
